Andrew Good

Andrew Good has a diverse work experience spanning various roles in finance and accounting. Andrew is currently working as a Senior Director, Controller at Maze Therapeutics, a position they have held since September 2022.

Prior to their current role, Andrew worked as a Finance Accounting Consultant at Geron Corporation from January 2022 to August 2022.

Andrew also had a long tenure at Geron Corporation, starting in 2006. During their time at Geron, they held several positions including Vice President, Finance and Controller from August 2014 to March 2019, Controller from January 2011 to July 2014, Assistant Controller from January 2008 to December 2010, and SEC Reporting Manager from August 2006 to December 2007.

Before joining Geron, Andrew worked at Deloitte as a Supervising Senior - Assurance Services in 2005, and at EY as a Supervising Senior - Assurance Services from 2002 to 2005.

Andrew Good attended California Polytechnic State University-San Luis Obispo from 1997 to 2002. During this time, they pursued a Bachelor of Science degree in Business Administration, focusing on Finance, Accounting, and Economics.